Ontology highlight
ABSTRACT: Background
The number of pulmonary nodules detected in the US is expected to increase substantially following recent recommendations for nationwide CT-based lung cancer screening. Given the low specificity of CT screening, non-invasive adjuvant methods are needed to differentiate cancerous lesions from benign nodules to help avoid unnecessary invasive procedures in the asymptomatic population. We have constructed a serum-based multi-biomarker panel and assessed its clinical accuracy in a retrospective analysis of samples collected from participants with suspicious radiographic findings in the Prostate, Lung, Chest and Ovarian (PLCO) cancer screening trial.Methods
Starting with a set of 9 candidate biomarkers, we identified 8 that exhibited limited pre-analytical variability
SUBMITTER: Birse CE
PROVIDER: S-EPMC5498919 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature